Literature DB >> 31838258

Program to improve mobility in aging (PRIMA) study: Methods and rationale of a task-oriented motor learning exercise program.

Jennifer S Brach1, Jessie M VanSwearingen2, Alexandra Gil2, Neelesh K Nadkarni3, Andrea Kriska4, Rakie Cham5, Subashan Perera6.   

Abstract

Walking difficulty is a common and costly problem in older adults. A potentially important yet unaddressed strategy to enhance walking ability through exercise intervention is to add a timing and coordination component in gait training (i.e. task specific timing and coordination exercise intervention) to the usual strength, endurance, and flexibility training. We describe the methods and rationale of a randomized single-blind, physical therapist supervised, exercise intervention trial to compare the effects of a standard strength, endurance, and flexibility program to a standard plus timing and coordination program in community-dwelling older adults walking slower than the desired gait speed of 1.2 m/s. Exercise sessions are twice weekly for 12 weeks. Participants are assessed at baseline, 12 weeks (post intervention), 24 weeks and 36 weeks. The primary outcome is gait speed, secondary outcomes represent components of the interventions (strength, endurance, flexibility, timing and coordination), and tertiary outcomes are measure of activity and participation (Late Life Function and Disability Instrument and physical activity). The findings of this trial will (1) establish if a standard-plus task specific timing and coordination program is superior to a standard strength and endurance program in improving mobility, activity and participation and (2) determine if the improvements are sustained over time. The information derived from this project will provide valuable insight into the prevention and management of walking difficulty, which is so common in older Americans.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Disability; Exercise; Physical therapy; Rehabilitation

Mesh:

Year:  2019        PMID: 31838258      PMCID: PMC6945812          DOI: 10.1016/j.cct.2019.105912

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  76 in total

1.  Assessment of physical activity with the Computer Science and Applications, Inc., accelerometer: laboratory versus field validation.

Authors:  J F Nichols; C G Morgan; L E Chabot; J F Sallis; K J Calfas
Journal:  Res Q Exerc Sport       Date:  2000-03       Impact factor: 2.500

2.  Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.

Authors:  J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-04       Impact factor: 6.053

3.  Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study.

Authors:  M A Newman; H Dawes; M van den Berg; D T Wade; J Burridge; H Izadi
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

4.  Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study.

Authors:  Matteo Cesari; Stephen B Kritchevsky; Brenda W H J Penninx; Barbara J Nicklas; Eleanor M Simonsick; Anne B Newman; Frances A Tylavsky; Jennifer S Brach; Suzanne Satterfield; Douglas C Bauer; Marjolein Visser; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  J Am Geriatr Soc       Date:  2005-10       Impact factor: 5.562

5.  The assessment of gait and mobility in the elderly.

Authors:  F J Imms; O G Edholm
Journal:  Age Ageing       Date:  1979-11       Impact factor: 10.668

6.  The effect of age on variability in gait.

Authors:  A Gabell; U S Nayak
Journal:  J Gerontol       Date:  1984-11

Review 7.  Aging, motor skill, and the energy cost of walking: implications for the prevention and treatment of mobility decline in older persons.

Authors:  Jessie M VanSwearingen; Stephanie A Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-02       Impact factor: 6.053

8.  A community-based diabetes prevention program: evaluation of the group lifestyle balance program delivered by diabetes educators.

Authors:  M Kaye Kramer; Janis R McWilliams; Hsiang-Yu Chen; Linda M Siminerio
Journal:  Diabetes Educ       Date:  2011 Sep-Oct       Impact factor: 2.140

9.  Improvement in usual gait speed predicts better survival in older adults.

Authors:  Susan E Hardy; Subashan Perera; Yazan F Roumani; Julie M Chandler; Stephanie A Studenski
Journal:  J Am Geriatr Soc       Date:  2007-10-03       Impact factor: 5.562

10.  Special article: gait measures indicate underlying focal gray matter atrophy in the brain of older adults.

Authors:  Caterina Rosano; Howard Aizenstein; Jennifer Brach; Allison Longenberger; Stephanie Studenski; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

View more
  3 in total

1.  Effect of Timing and Coordination Training on Mobility and Physical Activity Among Community-Dwelling Older Adults: A Randomized Clinical Trial.

Authors:  Jennifer S Brach; Subashan Perera; Valerie Shuman; Alexandra B Gil; Andrea Kriska; Neelesh K Nadkarni; Bonny Rockette-Wagner; Rakie Cham; Jessie M VanSwearingen
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Mobility of Older Adults: Gait Quality Measures Are Associated With Life-Space Assessment Scores.

Authors:  Anisha Suri; Andrea L Rosso; Jessie VanSwearingen; Leslie M Coffman; Mark S Redfern; Jennifer S Brach; Ervin Sejdić
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.591

3.  Improved Joint Mobility Associated with Reduced Inflammation Related to Consumption of Nopal Cactus Fruit Juice: Results from a Placebo-Controlled Trial Using Digital Inclinometry to Objectively Document Mobility of All Major Joints.

Authors:  Gitte S Jensen
Journal:  Clin Interv Aging       Date:  2020-12-09       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.